Segment disclosures

Company overview

POSITIVEID Corp

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 35 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Medical Devices

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=psid:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31177000 USD20180518Open filing evidence
2017-01-01 – 2017-12-31411000 USD20180402Open filing evidence
2017-07-01 – 2017-09-3077000 USD20171113Open filing evidence
2017-01-01 – 2017-09-30349000 USD20171113Open filing evidence
2017-04-01 – 2017-06-30177000 USD20170814Open filing evidence
2017-01-01 – 2017-06-30272000 USD20170814Open filing evidence
2017-01-01 – 2017-03-3195000 USD20180518Open filing evidence
2016-01-01 – 2016-12-31417000 USD20180402Open filing evidence
2016-07-01 – 2016-09-30145000 USD20171113Open filing evidence
2016-01-01 – 2016-09-30346000 USD20171113Open filing evidence
2016-04-01 – 2016-06-3080000 USD20170814Open filing evidence
2016-01-01 – 2016-06-30200000 USD20170814Open filing evidence
2016-01-01 – 2016-03-31120000 USD20170515Open filing evidence

Mobile Labs

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=psid:MobileLabsMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-314806000 USD20180402Open filing evidence
2017-07-01 – 2017-09-301373000 USD20171113Open filing evidence
2017-01-01 – 2017-09-303428000 USD20171113Open filing evidence
2017-04-01 – 2017-06-30986000 USD20170814Open filing evidence
2017-01-01 – 2017-06-302055000 USD20170814Open filing evidence
2017-01-01 – 2017-03-311069000 USD20180518Open filing evidence
2016-01-01 – 2016-12-315027000 USD20180402Open filing evidence
2016-07-01 – 2016-09-30868000 USD20171113Open filing evidence
2016-01-01 – 2016-09-304180000 USD20171113Open filing evidence
2016-04-01 – 2016-06-301768000 USD20170814Open filing evidence
2016-01-01 – 2016-06-303312000 USD20170814Open filing evidence
2016-01-01 – 2016-03-311544000 USD20170515Open filing evidence

Mobile Labs · January One Two Thousand And Eighteen Through January Thirty Two Thousand And Eighteen

Statement Business Segments · Award Type

Source dimensions us-gaap:StatementBusinessSegmentsAxis=psid:MobileLabsMember;us-gaap:AwardTypeAxis=psid:JanuaryOneTwoThousandAndEighteenThroughJanuaryThirtyTwoThousandAndEighteenMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31243000 USD20180518Open filing evidence

Molecular Diagnostics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=psid:MolecularDiagnosticsMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-31142000 USD20180402Open filing evidence
2017-07-01 – 2017-09-3017000 USD20171113Open filing evidence
2017-01-01 – 2017-09-30142000 USD20171113Open filing evidence
2017-04-01 – 2017-06-3062000 USD20170814Open filing evidence
2017-01-01 – 2017-06-30125000 USD20170814Open filing evidence
2017-01-01 – 2017-03-3163000 USD20180518Open filing evidence
2016-01-01 – 2016-12-31115000 USD20180402Open filing evidence
2016-07-01 – 2016-09-3052000 USD20171113Open filing evidence
2016-01-01 – 2016-09-3052000 USD20171113Open filing evidence